Investors didn't show much interest in one Intensity Therapeutics way or another today. It hasn't moved too much today but is slightly down, it lost -0.23% since yesterday.
The company isn't at an immediate support or resistance level that might be predictive. Intensity Therapeutics hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. INTS might find some support at the 5.97 level, buyers might push the price back up from here. But it's not very clear what will happen.